United States

Pfizer Animal Health Reaffirms its ‘Commitment to Veterinarians’ at TNAVC

January 13, 2011 Major collaborative research project to be announced at conference on Saturday, Jan.15

MADISON, NJ (January 13, 2011)—At the North AmericanVeterinary Conference this week in Orlando, Fla., Pfizer Animal Health is reaffirming its ongoing pledge to continuously support veterinarians throughout 2011, the 250th anniversary of the profession and World Veterinary Year. Under the banner of “Commitment to Veterinarians,” this platform is designed to address the unmet needs of practicing veterinarians and to support the veterinarian profession.

Launched at the end of 2010, Commitment to Veterinarians highlights Pfizer Animal Health’s pledge to invest, train, and educate current and future veterinarians, and to continue leading the industry in research and development and philanthropic support of the veterinary profession.

The United States Congress has declared 2011 World Veterinary Year, recognizing the increased roles that veterinarians are playing on the national stage. From homeland security to food safety, the well-being of the veterinary profession is integral to the success of the economy and the preservation of the food supply. Pfizer Animal Health proudly stands behind these efforts working to help overcome challenges faced by the veterinary community.

“The field of veterinary medicine is changing quickly and dramatically. The opportunities for practitioners to use their skills are ever expanding,but they often face daunting challenges as they try to realize their long-helddreams,” said Clint Lewis, President of U.S. Operations of Pfizer Animal Health.“It is critical that we invest, educate and support veterinarians and help them overcome ongoing challenges.”

“Pfizer understands that removing some of the obstacles will help develop and strengthen the next generation of veterinarians. We are honored to be able to start the new year by reaffirming our commitment to the profession,” Lewis added.

Pfizer’s Commitment to Veterinarians focuses on four key areas of veterinarian support: training and continuing education, research and development, investing in the future of the profession, and philanthropy.

On Saturday, Jan. 15, at TNAVC, Pfizer will participate in a luncheon announcing its financial and scientific support of the Morris Animal Foundation’s Canine Lifetime Health Project, the largest and most comprehensive study ever conducted in dogs to identify genetic, environmental and nutritional risk factors for the development of cancer and other diseases.

“This will be a landmark study for veterinary medicine. We are showing we are serious about supporting the future of the veterinary profession by funding one of the most important studies on companion animalhealth ever conducted,”  said David Haworth, DVM, PhD, Director, Global Alliances for Pfizer Animal Health. “Pfizer understands that this type of research is critical to addressing some of the most pressing issues in the field and we are proud to support this critical research.”

For more information about the Morris Animal Health Canine Lifetime Health Project, please visithttp://www.morrisanimalfoundation.org/our­research/major-health-campaigns/clhp.html. For more information on Commitment to Veterinarians, visit the Pfizer Animal Health booth at TNAVC.

Pfizer Inc: Working together for a healthier world™
At Pfizer, we apply science and our global resources to improve health and well-being at every stage of life. We strive to set the standard for quality, safety and value in the discovery, development and manufacturing of medicines for people and animals. Our diversified global health care portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional productsand many of the world's best-known consumer products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time.  Consistent with our responsibility as the world's leading biopharmaceutical company, we also collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us. To learn more about our commitments to animal health, please visit us at www.pfizerAH.com.

Media Contacts:
Katy Funk
(410) 821 8220
katyf@IMRE.com

Rebecca Cisek
(973) 660 ‐5565
rebecca.cisek@pfizer.com